Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
US8614299B2 · kind B2 · utility
25Cited by
6References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2010 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | May 11, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2015/8518
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide, and to the use of said antibodies in the field of Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.